$VSEC

CUOMO JOHN A sold $4.2M of VSEC

CUOMO JOHN A (CEO and President) sold 17,500 shares of VSE CORP (VSEC) at an average of $242.49 ($238.66–$245.04, $4.24M total) across 8 trades on 2026-08-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · CUOMO JOHN A
Published Aug 19, 2026, 8:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 19, 2026, 10:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VSEC
Bearish
medium confidence
Mentioned
$VSEC
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VSECBearishLow
01

Why it matters

The disclosed sale provides fresh data for traders assessing insider sentiment and may influence short‑term price action.

02

Market read

Primary insider sale news; modest scale but directly relevant to VSEC shareholders.

03

What to watch

Potential tax planning or diversification motives behind the 10b5-1 execution.

Relevance 5/10Novelty 8/10Timing: post-market 2026-08-17

Background

Form 4 filing discloses insider transactions; a 10b5-1 plan pre‑arranges sales to avoid timing concerns.

Company-level read

Ticker impact

$VSECBearishMedium confidence
Context

CEO John A. Cuomo sold 17,500 shares for $4.24M via a 10b5-1 plan on 2026-08-17.

Expected impact

Possible modest downside pressure in the next trading session.

Evidence & confidence

The sale size is modest relative to market cap, but the insider is the CEO, making the move noteworthy.

Market effects

Minimal impact on the broader sector; only relevant to VSEC investors.

None

None

Counterpoint

The sale could be a routine liquidity event unrelated to company outlook.

Key entities

  • VSE Corp

    Issuer of the securities sold.

  • John A. Cuomo

    CEO and President of VSE Corp, reporting the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VSECMed

Guggenheim initiates VSE stock with neutral on margin concerns

Guggenheim initiated VSE Corporation (VSEC) with a neutral rating, citing margin concerns and the need for operational improvements. The company reported Q2 2026 earnings of $1.75 per share on $449.1M revenue, beating estimates. Stifel raised its price target to $260, maintaining a Buy rating. VSEC's EBITDA grew 98% YoY to $86M, with margins expanding to 19.2%.

$VSECMedAI 8/10

A Record Quarter Raises The Stakes For VSE Corp. (VSEC)

VSE Corporation (VSEC) reported Q2 revenue of $449.1M, up 65% YoY, with organic growth of 14%. Adjusted EBITDA rose to $86.0M, with a margin of 19.2%. The company completed two major acquisitions, raising full-year guidance. Debt increased to $966.7M, and free cash flow was negative $50.0M for H1 2026. The stock trades at 25x forward earnings.

$VSECMed

VSE (VSEC) Q2 2026 Earnings Call Transcript

VSE Corp (VSEC) Q2 2026 earnings call said it delivered record revenue and profitability. Revenue rose to $449 million, up 65% YoY, with 14% organic growth. Adjusted EBITDA was $86 million, up 98% YoY, and margin reached a record 19.2%. VSE said it closed the PAG deal May 5 (~$2B) and NorthStar on April 1, and raised full-year revenue and margin guidance.